Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994. The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Company has been a pioneer and leader into the Indian Ophthalmology market in the eye care division. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. It has presence in Tamil Nadu, Kerala and Rajasthan states.
The Company is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services. As at 31st March 2025, the Company is operating in 61 locations in India.
In 1957, the late parents - Dr Tahira Agarwal and Dr Jaiveer Agarwal, opened the fir ...st Dr. Agarwal's Eye Hospital as a single facility in Chennai in year 1957. Till 30 Sep.'94 the eye care facility was provided by the family through various partnership firms owned by the family members. Since Oct.'94, the entire hospital business is carried on by the company. As such, it has the distinct advantage of capitalising on the reputation built by the Agarwals over a period of 37 years and aim at further growth by carrying out immediate expansion.
In 1995-96, the company commenced commercial production of pharmaceutical products in a limited way.
During 1996-97, it installed Lasik Excimer Laser which is of its only kind in India and the company has been constantly striving to update the surgical techniques by adopting innovative methods and by employing the latest equipments both for Surgery and Research.
During 2004, the Hospital started their Jaipur branch. It opened a Medical Enclave at Nungambakkam, Chennai and a Franchisee Centre at Thiruvanmyur, Chennai as Referral Centres of the Hospital. The Hospital carried out eye transplant operations. Tele-ophthalmic service was started by the Hospital during 2005. 14 new hospitals started their operations during the year 2008 in various parts of Chennai city and Tamil Nadu and Andhra Pradesh.
The Company relocated Salem branch during the financial year 2020-21. In FY 2022, it added a branch in Kallakurichi. It had 3 centres across the core markets as pilot projects - Gowriwakkam, Ambur, and Valliyur. In FY22, the Hospital initiated the process of establishing a new centre on Cathedral Road.
During the FY 2023, the Company opened a branch in Nagercoil, and entered the Kerala market with a state-of-the-art branch in Cochin. The Company opened 3 vision centres in Chengalpattu, Gudiyattam, and Sankarankovil.
1. Can I buy Dr Agarwals Eye Hospital Ltd from PL Capital? ›
Yes, you can invest in Dr Agarwals Eye Hospital Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Dr Agarwals Eye Hospital Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Dr Agarwals Eye Hospital Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Dr Agarwals Eye Hospital Ltd pay dividends? ›
Yes, Dr Agarwals Eye Hospital Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Dr Agarwals Eye Hospital Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.
3. What is the current share price of Dr Agarwals Eye Hospital Ltd ? ›
As of
04-12-2025 the share price for Dr Agarwals Eye Hospital Ltd. is 5496.95 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Dr Agarwals Eye Hospital Ltd ? ›
The 52-week high and low of Dr Agarwals Eye Hospital Ltd share price is ₹ 3500 - ₹ 7300 as of
04-12-2025 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
